Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2019-12-04 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically detailing Related Party Transactions on a consolidated basis for the period ended September 30, 2019. It includes names of key managerial personnel, relatives, and other related parties, along with transaction amounts. This type of disclosure is a regulatory compliance filing related to related party transactions, not a full financial report or audit report. It is not an announcement of voting results, management changes, or earnings release. The document is a regulatory disclosure under SEBI LODR requirements, which fits best under Regulatory Filings (RNS) as it does not constitute a standalone audit report or annual/interim report but a specific regulatory disclosure.
2019-12-04 English
Reply to Clarification- Financial results
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including cash flow from operating, investing, and financing activities for the half year ended 30-09-2019. It includes standalone and consolidated figures, adjustments, and cash equivalents. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length (7848 characters) supports it being a substantive report rather than a brief announcement or certification. H1 2020
2019-11-22 English
Financial Result Updates
Regulatory Filings
2019-11-12 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying that there is no price sensitive information or undisclosed events affecting the company's share price. It is a response to an inquiry about price movement and explicitly states no new announcements or events that would impact share price or volume. The document is short (1609 characters) and does not contain any financial data, report, or detailed disclosures. It is essentially a regulatory communication clarifying the absence of material information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-11-05 English
Board Meeting — Financial Results
Regulatory Filings
2019-10-31 English
Updates
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no substantive text content. The true document length is only 228 characters, which is extremely short and contains no financial data, report content, or announcements. It does not contain any report, announcement, or certification. Given the lack of content, this document does not fit any specific report category and defaults to the fallback category for miscellaneous filings.
2019-10-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.